ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/18 | 1,895 | 1,970 | 1,882 | 1,957 | +54 | +2.8% | 1,074,300 |
2021/01/15 | 1,877 | 1,916 | 1,847 | 1,903 | +46 | +2.5% | 909,100 |
2021/01/14 | 1,915 | 1,939 | 1,857 | 1,857 | -61 | -3.2% | 1,117,000 |
2021/01/13 | 1,870 | 1,918 | 1,860 | 1,918 | +57 | +3.1% | 912,000 |
2021/01/12 | 1,845 | 1,872 | 1,835 | 1,861 | +5 | +0.3% | 664,200 |
2021/01/08 | 1,840 | 1,872 | 1,828 | 1,856 | +40 | +2.2% | 793,900 |
2021/01/07 | 1,821 | 1,846 | 1,811 | 1,816 | -1 | -0.1% | 671,000 |
2021/01/06 | 1,787 | 1,824 | 1,765 | 1,817 | +25 | +1.4% | 606,500 |
2021/01/05 | 1,801 | 1,816 | 1,766 | 1,792 | -43 | -2.3% | 831,500 |
2021/01/04 | 1,809 | 1,835 | 1,742 | 1,835 | +27 | +1.5% | 1,233,100 |
2020/12/30 | 1,900 | 1,900 | 1,807 | 1,808 | -78 | -4.1% | 1,277,100 |
2020/12/29 | 1,853 | 1,905 | 1,842 | 1,886 | +40 | +2.2% | 1,279,100 |
2020/12/28 | 1,840 | 1,864 | 1,827 | 1,846 | -3 | -0.2% | 844,500 |
2020/12/25 | 1,825 | 1,856 | 1,808 | 1,849 | +14 | +0.8% | 736,900 |
2020/12/24 | 1,770 | 1,847 | 1,745 | 1,835 | +58 | +3.3% | 1,025,900 |
2020/12/23 | 1,734 | 1,777 | 1,708 | 1,777 | +55 | +3.2% | 1,126,400 |
2020/12/22 | 1,833 | 1,835 | 1,711 | 1,722 | -118 | -6.4% | 1,758,100 |
2020/12/21 | 1,885 | 1,909 | 1,826 | 1,840 | -23 | -1.2% | 994,900 |
2020/12/18 | 1,850 | 1,879 | 1,832 | 1,863 | +13 | +0.7% | 721,700 |
2020/12/17 | 1,853 | 1,868 | 1,827 | 1,850 | -3 | -0.2% | 672,800 |
2020/12/16 | 1,858 | 1,884 | 1,840 | 1,853 | -5 | -0.3% | 572,700 |
2020/12/15 | 1,884 | 1,888 | 1,840 | 1,858 | -15 | -0.8% | 651,200 |
2020/12/14 | 1,841 | 1,906 | 1,826 | 1,873 | +29 | +1.6% | 805,600 |
2020/12/11 | 1,824 | 1,847 | 1,814 | 1,844 | +24 | +1.3% | 870,000 |
2020/12/10 | 1,850 | 1,867 | 1,808 | 1,820 | -65 | -3.4% | 886,400 |
2020/12/09 | 1,889 | 1,889 | 1,833 | 1,885 | +6 | +0.3% | 836,200 |
2020/12/08 | 1,825 | 1,888 | 1,804 | 1,879 | +32 | +1.7% | 1,049,500 |
2020/12/07 | 1,905 | 1,919 | 1,834 | 1,847 | -72 | -3.8% | 1,311,200 |
2020/12/04 | 1,946 | 1,950 | 1,893 | 1,919 | -39 | -2% | 1,244,800 |
2020/12/03 | 1,980 | 2,014 | 1,943 | 1,958 | -31 | -1.6% | 1,085,600 |
2020/12/02 | 1,932 | 2,066 | 1,920 | 1,989 | +58 | +3% | 2,604,800 |
2020/12/01 | 1,949 | 1,964 | 1,910 | 1,931 | -17 | -0.9% | 775,100 |
2020/11/30 | 1,921 | 1,965 | 1,909 | 1,948 | +20 | +1% | 881,100 |
2020/11/27 | 1,932 | 1,965 | 1,900 | 1,928 | -9 | -0.5% | 990,700 |
2020/11/26 | 1,860 | 1,945 | 1,858 | 1,937 | +79 | +4.3% | 1,321,100 |
2020/11/25 | 1,951 | 1,963 | 1,850 | 1,858 | -100 | -5.1% | 1,806,000 |
2020/11/24 | 1,935 | 1,963 | 1,905 | 1,958 | +9 | +0.5% | 1,184,800 |
2020/11/20 | 1,940 | 1,956 | 1,925 | 1,949 | -12 | -0.6% | 754,800 |
2020/11/19 | 1,964 | 1,982 | 1,929 | 1,961 | -3 | -0.2% | 845,200 |
2020/11/18 | 1,974 | 2,033 | 1,940 | 1,964 | -1 | -0.1% | 1,686,900 |
2020/11/17 | 2,085 | 2,120 | 1,960 | 1,965 | -110 | -5.3% | 2,180,200 |
2020/11/16 | 1,974 | 2,116 | 1,874 | 2,075 | +101 | +5.1% | 2,978,000 |
2020/11/13 | 1,976 | 1,994 | 1,936 | 1,974 | +3 | +0.2% | 1,295,400 |
2020/11/12 | 2,048 | 2,063 | 1,947 | 1,971 | -76 | -3.7% | 1,765,700 |
2020/11/11 | 1,918 | 2,057 | 1,910 | 2,047 | +98 | +5% | 2,361,400 |
2020/11/10 | 1,968 | 2,016 | 1,928 | 1,949 | -50 | -2.5% | 1,717,800 |
2020/11/09 | 1,988 | 2,005 | 1,932 | 1,999 | +29 | +1.5% | 1,791,400 |
2020/11/06 | 1,949 | 2,044 | 1,925 | 1,970 | +18 | +0.9% | 2,717,300 |
2020/11/05 | 1,983 | 2,020 | 1,916 | 1,952 | -33 | -1.7% | 2,128,200 |
2020/11/04 | 1,939 | 1,989 | 1,881 | 1,985 | +77 | +4% | 2,581,300 |
1051~
1100
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 241,500円 | +21.7% | +999.9% | 0.00% | 10.06倍 | 3.33倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
東和薬品 | 263,700円 | +15.0% | -7.3% | 2.65% | 8.65倍 | 0.82倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 234,300円 | +14.2% | +41.0% | 1.96% | 11.48倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 148,600円 | +8.8% | +99.9% | 3.50% | 9.49倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム